Clasp Therapeutics
Cambridge, United States· Est.
Clasp Therapeutics designs T cell engager therapies targeting cancer-specific mutations for oncology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $150M
About
Clasp Therapeutics designs T cell engager therapies targeting cancer-specific mutations for oncology.
OncologyImmunologyAntibodies
Funding History
1Total raised:$150M
Venture$150M